These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [New method in the therapy of cancer. Interview granted to Minerva Medica by Prof. Augusto Pederzini]. Carafa M Minerva Med; 1973 Apr; 64(25):3-6. PubMed ID: 4709744 [No Abstract] [Full Text] [Related]
29. Managing HIV. Part 4: Primary therapy. 4.2 Immune-based therapy for HIV infection. Benson EM; French MA; Schooley RT Med J Aust; 1996 Mar; 164(5):297-300. PubMed ID: 8628166 [TBL] [Abstract][Full Text] [Related]
32. [Immunotherapy in non-allergic diseases]. Español T Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379 [TBL] [Abstract][Full Text] [Related]
33. Modern techniques of immunomodulation in rheumatoid arthritis. Codreanu C Roum Arch Microbiol Immunol; 1993; 52(3):149-56. PubMed ID: 7833528 [No Abstract] [Full Text] [Related]
34. [Immunomodulatory/suppressive treatments in neurology]. Schluep M; Chofflon M; Kuntzer T; Du Pasquier R Rev Med Suisse; 2005 May; 1(18):1229-32. PubMed ID: 15977712 [TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy]. Xie SW Zhonghua Nei Ke Za Zhi; 1984 Mar; 23(3):176-8. PubMed ID: 6207997 [No Abstract] [Full Text] [Related]
38. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
39. [Immunosuppression and immunopotentiation in the treatment of skin diseases]. Wereide K Tidsskr Nor Laegeforen; 1983 Apr; 103(10):841-4. PubMed ID: 6879520 [No Abstract] [Full Text] [Related]
40. [New therapies in the management of seropositive persons]. Riou JM Soins; 2009 Apr; (734):54. PubMed ID: 19475834 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]